Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Chemoprevention × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3465 Neoplasms 2678 Prostatic Neoplasms 1572 Colorectal Neoplasms 1291 Lung Neoplasms 1179 Motor Activity 721 Head and Neck Neoplasms 624 Pancreatic Neoplasms 597 Colonic Neoplasms 579 Uterine Cervical Neoplasms 577 Carcinoma, Non-Small-Cell Lung 568 Carcinoma, Hepatocellular 558 Rectal Neoplasms 513 Stomach Neoplasms 485 Brain Neoplasms 429 Ovarian Neoplasms 393 Anxiety Disorders 373 Pain 371 Neoplasm Metastasis 341 Polycystic Ovary Syndrome 339 Esophageal Neoplasms 335 Urinary Bladder Neoplasms 320 Precursor Cell Lymphoblastic Leukemia-Lymphoma 313 Fatigue 299 Melanoma 291 Multiple Myeloma 290 Lymphoma 281 Depression 267 Endometrial Neoplasms 255 Liver Neoplasms 248

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04266353 2023-05-09

Effect of Resveratrol on Serum IGF2 Among African American Women

Loma Linda University

Phase NA Withdrawn

Chemoprevention

Data powered by HemOnc (CC BY 4.0) Colophon ⚡